Zeropecia-F Solution is a topical formulation containing Minoxidil (10% w/v) and Finasteride (0.1% w/v), indicated for the treatment of androgenetic alopecia in adult males. Minoxidil, a potent vasodilator, promotes hair follicle stimulation and prolongs the anagen phase of the hair growth cycle, thereby enhancing hair density and thickness. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor implicated in hair follicle miniaturization and progressive hair loss. The combined action of these active ingredients provides a synergistic effect, addressing both the hormonal and vascular components of hair loss. Zeropecia-F Solution is applied topically to the affected scalp areas once daily, ensuring localized delivery with minimal systemic absorption. Clinical studies have demonstrated its efficacy in improving hair regrowth and slowing hair loss progression when used consistently over several months. Patients should be advised to avoid contact with eyes and mucous membranes and to discontinue use if irritation occurs. This product is contraindicated in women and children and should be used under medical supervision, particularly in individuals with hypersensitivity to any component or underlying scalp conditions. Regular follow-up is recommended to monitor therapeutic response and adverse effects.